Suppr超能文献

安纳托利亚东南部地区原发性和继发性幽门螺杆菌对克拉霉素耐药的流行情况及可能的相关辅助因素:数据报告

The prevalence of primary and secondary Helicobacter pylori resistance to clarithromycin and probable contributing cofactors: data from southeastern Anatolia.

作者信息

Tüzün Yekta, Bayan Kadim, Yilmaz Serif, Dursun Mehmet, Ozekinci Tuncer

机构信息

Department of Gastroenterology, Dicle University Faculty of Medicine, Diyarbakir, Turkey.

出版信息

Hepatogastroenterology. 2008 Jan-Feb;55(81):289-93.

Abstract

BACKGROUND/AIMS: Antibiotic resistance of Helicobacter pylori is the most important reason for failure in its eradication. We aimed to determine the prevalence of primary and secondary H. pylori resistance to clarithromycin in isolated H. pylori from dyspeptic patients in southeastern Anatolia and to evaluate the cofactors affecting this clinical problem.

METHODOLOGY

The study involved adult patients who had already been diagnosed with symptomatic H. pylori infection based on rapid urease test, gastric histopathological examination and culture. H. pylori strains were isolated from antral biopsies taken during upper endoscopy in 142 dyspeptic patients with no previous therapy against the microorganism. MICs of clarithromycin were determined by E-test. Patients were treated for 14 days with standard triple-agent protocol. H. pylori eradication rate was assessed after 8 weeks. Each patient was re-interviewed to determine secondary resistance. Primary clarithromycin resistance was defined as pre-treatment resistance, while secondary as after treatment resistance. Strains were considered resistant to clarithromycin if the MIC > 1 microg/mL.

RESULTS

In total 213-105 women and 108 men-patients was enrolled to the study. The mean age was 35.5+/-14.1 years. In 142 (66.7%) patients out of the total patients enrolled in the study, H. pylori was detected. H. pylori could be cultured from only 61 (43%) of them. In 16.4% of the cases, primary clarithromycin resistance was noted. After 8 weeks, seventy-seven (54.2%) of the 142 patients were reevaluated. Helicobacter pylori eradication could be achieved in 68.8% of them. The proportion of H. pylori eradication in clarithromycin-sensitive patients was 75.8% and the respective proportion was 10% for resistant cases. In the group where H. pylori was still positive the secondary resistance percentage was found to be 27.2%.

CONCLUSIONS

The prevalence of primary clarithromycin resistance is relatively high in our geographical area. Secondary resistance rate was 27.2%. None of the criteria of age, gender, presence of endoscopic lesions, detected H. pylori concentration and gastritis activity showed any effect on the primary resistance.

摘要

背景/目的:幽门螺杆菌的抗生素耐药性是其根除失败的最重要原因。我们旨在确定安纳托利亚东南部消化不良患者分离出的幽门螺杆菌对克拉霉素的原发性和继发性耐药率,并评估影响这一临床问题的相关因素。

方法

本研究纳入了已根据快速尿素酶试验、胃组织病理学检查和培养确诊为有症状幽门螺杆菌感染的成年患者。从142例既往未接受过针对该微生物治疗的消化不良患者的上消化道内镜检查时采集的胃窦活检组织中分离幽门螺杆菌菌株。采用E试验测定克拉霉素的最低抑菌浓度(MIC)。患者采用标准三联疗法治疗14天。8周后评估幽门螺杆菌根除率。对每位患者进行再次访谈以确定继发性耐药情况。原发性克拉霉素耐药定义为治疗前耐药,继发性耐药定义为治疗后耐药。如果MIC>1μg/mL,则菌株被视为对克拉霉素耐药。

结果

总共213例患者(105例女性和108例男性)纳入本研究。平均年龄为35.5±14.1岁。在纳入研究的所有患者中,142例(66.7%)检测到幽门螺杆菌。其中仅61例(43%)培养出幽门螺杆菌。16.4%的病例存在原发性克拉霉素耐药。8周后,对142例患者中的77例(54.2%)进行了重新评估。其中68.8%的患者实现了幽门螺杆菌根除。克拉霉素敏感患者的幽门螺杆菌根除率为75.8%,耐药患者的相应根除率为10%。在幽门螺杆菌仍为阳性的组中,继发性耐药率为27.2%。

结论

在我们所在地区,原发性克拉霉素耐药率相对较高。继发性耐药率为27.2%。年龄、性别、内镜下病变的存在、检测到的幽门螺杆菌浓度和胃炎活动度等指标均未对原发性耐药产生任何影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验